Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II

Inclusion Criteria: * Male or female subject 18 to 90 years, of any race. * Patients with proven Peripheral Arterial Disease (PAD) in Doppler Ultrasound and Ankle-Brachial Pressure Index (ABPI ≤ 0.9 in one leg) * Subject with stable (\>3 month) PAD Fontaine Stage II. * Aortoiliac vessels with no significant hemodynamic disturbances , as confirmed by recent (\<30 days) clinical examination * Subject has intermittent claudication and claudication pain of the calf * Subject has stable intermittent claudication (\>3 month and not more than one year) with initial claudication distance not more than 250 meters, as determined by treadmill test (3.2 km/h, 10% grade) * Subject willing to participate as evidenced by signing the written informed consent. * Treatment with Aspirin or Clopidogrel for at least 7 days * Willingness to undergo standardized walking exercise Exclusion Criteria: * Ankle-Brachial Pressure Index (ABI) above 0.8 in both legs. In Diabetic patients with no compressible arteries ABI above 40 mm/Hg of the higher pressure measured in both arms. * Inability to walk * Chronic respiratory insufficiency (severe obstructive or restrictive) * Coronary artery disease with angina * Stroke, myocardial infarction or other acute vascular events in the last 3 months * Mild-Severe congestive heart failure * Degenerative or inflammatory hip, knee, ankle or foot joint lesions interfering with walking * Spinal stenosis or disc lesions with lower limb motor sensory defects * Leg trauma, limb or skin infection or edema * Recent (6 months) abdominal, cardiothoracic, vascular or orthopedic (lower limb) surgery * Subject after crural or pedal bypass surgery * Subject with neuropathy * Uncontrolled arterial hypertension * Morbid obesity (BMI \>35.0) * Need for concomitant medication with potential vascular activity * Routinely use of pain relief medications (i.e. NSAIDs, Narcotics etc) * Expected weak compliance * Subject requires surgical or endovascular intervention for PAD * Subject has known allergy to device components (sleeve fabric). * Subject has medical conditions that may be worsened by concomitant use of the device (i.e. recent (1 year) Deep Vein Thrombosis). * Subject participates in any other clinical study at the same time